Olin Corp (OLN)
52.06
-0.22
(-0.42%)
USD |
NYSE |
May 01, 16:00
52.07
+0.01
(+0.02%)
After-Hours: 20:00
Olin SG&A Expense (Quarterly): 95.10M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 95.10M |
December 31, 2023 | 102.80M |
September 30, 2023 | 90.90M |
June 30, 2023 | 101.20M |
March 31, 2023 | 106.10M |
December 31, 2022 | 97.90M |
September 30, 2022 | 92.70M |
June 30, 2022 | 99.00M |
March 31, 2022 | 104.30M |
December 31, 2021 | 102.20M |
September 30, 2021 | 107.20M |
June 30, 2021 | 100.60M |
March 31, 2021 | 106.90M |
December 31, 2020 | 112.90M |
September 30, 2020 | 112.70M |
June 30, 2020 | 99.70M |
March 31, 2020 | 96.70M |
December 31, 2019 | 102.10M |
September 30, 2019 | 110.80M |
June 30, 2019 | 97.00M |
March 31, 2019 | 107.00M |
December 31, 2018 | 109.00M |
September 30, 2018 | 110.80M |
June 30, 2018 | 110.30M |
March 31, 2018 | 100.50M |
Date | Value |
---|---|
December 31, 2017 | 101.00M |
September 30, 2017 | 91.10M |
June 30, 2017 | 84.80M |
March 31, 2017 | 92.90M |
December 31, 2016 | 97.80M |
September 30, 2016 | 82.00M |
June 30, 2016 | 79.30M |
March 31, 2016 | 88.10M |
December 31, 2015 | 63.60M |
September 30, 2015 | 35.80M |
June 30, 2015 | 39.90M |
March 31, 2015 | 47.00M |
December 31, 2014 | 39.10M |
September 30, 2014 | 41.80M |
June 30, 2014 | 41.70M |
March 31, 2014 | 43.50M |
December 31, 2013 | 55.70M |
September 30, 2013 | 36.50M |
June 30, 2013 | 48.70M |
March 31, 2013 | 49.10M |
December 31, 2012 | 37.40M |
September 30, 2012 | 42.40M |
June 30, 2012 | 45.10M |
March 31, 2012 | 43.70M |
December 31, 2011 | 39.60M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
90.90M
Minimum
Sep 2023
112.90M
Maximum
Dec 2020
101.94M
Average
101.65M
Median
SG&A Expense (Quarterly) Benchmarks
The Chemours Co | 142.00M |
Ingevity Corp | 43.40M |
Avantor Inc | 424.20M |
Balchem Corp | 32.72M |
Innospec Inc | 102.30M |